Céline Olmiere received her PhD in Molecular and cellular biology from the Claude Bernard University in Lyon, after research in virology (INSERM /Institut Pasteur) and prions (AFSSA). Céline started her pharma career in the clinical operation department of Sanofi Pasteur. She joined the clinical department of Laboratoires Thea in 2007. In 2011, Céline became the head of non-clinical and scientific assessments for the group. She also seeks new developments/molecules in ophthalmology for Théa Group. For more than 12 years now, Céline has focused on Ophthalmology R&D and has played a key role in the registration and the launch of dozen of products. Céline is currently based on the USA.